Upsher-Smith Receives Tentative NDA Approval for Vogelxo™ (testosterone) Gel CIII

MAPLE GROVE, Minn., Aug. 16, 2013 /PRNewswire/ — Upsher-Smith Laboratories, Inc., today announced that it has received tentative approval from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for Vogelxo™ (testosterone) gel for topical use CIII

http://www.pharmalive.com/upsher-smith-gets-tentative-nda-approval-for-vogelxo-gel

Image may be NSFW.
Clik here to view.